AHR and psoriasis: We previously demonstrated that the AHR agonist TCDD induced inflammation through autophagy inhibition using an in vitro psoriasis keratinocyte model and ex vivo psoriatic skin tissue study, and these findings are consistent with those noted in this study [31].